rss
Br J Ophthalmol 88:708-713 doi:10.1136/bjo.2003.032250
  • Perspective

Cannabinoids and glaucoma

  1. I Tomida1,
  2. R G Pertwee2,
  3. A Azuara-Blanco1
  1. 1Department of Ophthalmology, Aberdeen Royal Infirmary, University of Aberdeen, UK
  2. 2Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, UK
  1. Correspondence to: A Azuara-Blanco PhD FRCS(Ed), The Eye Clinic, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK; Aazblancoaol.com
  • Accepted 4 October 2003

Abstract

Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

Footnotes